FinlandFinland

Linking up: EU biobank synergies

07.03.2010

Helsinki/Hinxton – Finland has pledged EUR1.85m to help create world-class bio­informatics, biobanking and translational research infrastructures, the European Bioinformatics Institute (EBI) at the European Molecular Laboratory (EMBL) in Hinxton reported in February. The investment comes as part of the linkage of three large EU projects: “European Life Sciences Infrastructure for Biological Innovation” (ELIXIR), “Biobanking and Biomolecular Resources Research Infrastructure” (BBMRI), and “European Advanced Translational Research Infrastructure in Medicine” (EATRIS).
The commitment is Finland’s first specific European investment in this area, and follows Denmark’s recent EUR5.3m ELIXIR funding pledge. The Finnish money is earmarked for pilot studies in 2010. a1m of the funding is to be provided by the Ministry of Education, with EUR0.85m in co-financing coming from a consortium consisting of the Institute for Molecular Medicine Finland (FIMM), the CSC – IT Center for Science, and the National Institute for Health and Welfare (THL). ”A small country should concentrate its European investments in those areas that are of critical importance, and where synergies may arise,” FIMM director Olli Kallioniemi said. EMBL-EBI Director Janet Thornton, added that “the close interaction between the biomedical research infrastructures in Finland will help Europe to develop a fully-integrated data approach.”

FinlandFinland

08.03.2012

The vaccine research centre of the University of Tampere in Finland has out­licenced a candidate combined prophylactic vaccine against norovirus and rota­virus infections. The Japanese vaccine venture UMN Pharma Inc. acquired the...

FinlandFinland

07.03.2012

Finnish protein manufacturer Vectron Biosolutions AS has completed a study comparing different expression technologies. According to Vectron, their proprietary E. coli expression technology gave higher yields for seven out of ten...

FinlandFinland

02.03.2012

Lappeenranta – Finnish paper industry major UPM plans to invest in an industry-scale biorefinery producing biofuels from crude tall oil, a by-product of the wood pulp manufacturing process. UPM’s total investment will amount to...

FinlandFinland

18.12.2011

Helsinki/Göttingen – Finnish laboratory supplier Biohit Oyj has sold its liquid handling business for €68m to German process and labtech provider Sartorius AG. Osmo Suovaniemi, founder and Chairman of the Board at Biohit,...

FinlandFinland

17.12.2011

Porvoo/Chalfont St. Giles – GE Healthcare and Neste Jacobs have formed a strategic alliance to drive worldwide self-sufficiency in blood plasma fractionation. Finnish-based Neste Jacobs Oy, a global expert in plant engineering...

FinlandFinland

31.10.2011

Bresso/Turku – The wedding's off between Newron and Biotie. The bride has run away. Shares in Italy's Newron Pharmaceuticals plunged after its proposed merger with Biotie Therapies Corp was called off by the Finnish firm....

FinlandFinland

28.09.2011

Turku/ Bresso – It is both good and bad news for the Italian biotechnology sector: Finnish Biotie Therapies ASA has signed an agreement to acquire Newron Pharmaceuticals S.p.A. for €45 million. On the down side, Italy loses one...

FinlandFinland

04.04.2011

Hafnarfjodur – Actavis Group CEO Claudio Albrecht announced at the beginning of February that the company may go public within the next 2-3 years, although it isn’t clear whether the generics manufacturer would conduct an IPO,...

Displaying results 1 to 10 out of 96

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-finland/article/linking-up-eu-biobank-synergies.html

Print Magazine

Product of the week

Products

Events

All Events

Current issue

All issues